medical guideline
首页
中医/中西医结合指南
肿瘤学指南
泌尿外科指南
关于我们
郑重声明
联系我们
首页
肿瘤学指南
检索结果
人体系统
运动
骨肿瘤
软组织肿瘤
骨与软组织肿瘤
硬纤维瘤
骶尾部畸胎瘤
神经
中枢神经系统肿瘤
嗜铬细胞瘤和副神经节瘤
副神经节瘤
胶质细胞瘤
前庭神经鞘瘤
星形胶质细胞瘤和少突胶质细胞瘤
弥漫性胶质瘤
神经纤维瘤
神经细胞瘤
神经内分泌肿瘤
内分泌
甲状腺肿瘤
垂体肿瘤
肾上腺肿瘤
甲状旁腺肿瘤
胸腺肿瘤
神经内分泌肿瘤
循环
心脏肿瘤
淋巴瘤
骨髓瘤
白血病
血液肿瘤
血管瘤
呼吸
肺癌
鼻咽癌
喉部肿瘤
下咽癌
鼻腔和副鼻窦癌
呼吸道肿瘤
鼻颅咽管瘤
淋巴管肌瘤
消化
胰腺肿瘤
口腔癌
肛门癌
口咽癌
胆囊癌
胆管肿瘤
直肠癌
结肠癌
胃癌
小肠癌
肝癌
大肠肿瘤
唾液腺癌
阑尾肿瘤
食管肿瘤
肝肿瘤
壶腹肿瘤
肝胆癌
结直肠肿瘤
食管胃肿瘤
胃肠道肿瘤
消化道肿瘤
泌尿
膀胱肿瘤
肾癌
脐尿管癌
尿路上皮癌
肾血管平滑肌脂肪瘤
泌尿生殖肿瘤
生殖
女性
子宫肿瘤
卵巢肿瘤
乳腺肿瘤
阴道肿瘤
输卵管癌
外阴癌
妊娠滋养细胞肿瘤
妇科肿瘤
男性
前列腺肿瘤
性索间质瘤
睾丸肿瘤
阴茎癌
男性乳腺肿瘤
泌尿生殖肿瘤
其他
症状管理
治疗方案
诊断/检测/评估方法
预防和筛查
COVID-19大流行癌症患者相关指导建议
皮肤肿瘤
黑色素瘤
头颈部肿瘤
康复营养
生育能力
体力活动
心理健康
腹膜肿瘤
实体瘤
胸部肿瘤
长期监测
Cowden综合征
转诊
遗传性癌症综合征
癌症患者其他类问题管理
寡转移性疾病
基因测序
易感基因变异的分类
外科肿瘤
罕见癌症
不明原因癌症
纤维瘤
腹部肿瘤
老年肿瘤
儿童/青少年肿瘤
人类微生物组与癌变
检索结果
按关键字
按标题
按关键词
按摘要
按作者
按期刊
按发表年份
共搜索到
147条
与
BL
有关的结果
Controversies, Consensus, and Collaboration in the Use of 131I Therapy in Differentiated Thyroid Cancer: a Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular I
2019年 发布于
Thyroid
29卷 第4期
所属人体系统:
内分泌
|
甲状腺肿瘤
American Thyroid Association
the European Association of Nuclear Medicine
the Society of Nuclear Medicine and Molecular I
Adjuvant Therapy
Consensus
Differentiated Thyroid Cancer
Radioiodine-refractory Thyroid Cancer
Remnant Ablation
指南简介
原文链接
EANO-EURACAN Clinical Practice Guideline for Diagnosis, Treatment, and Follow-up of Post-pubertal and Adult Patients with Medulloblastoma
2019年 发布于
Lancet Oncol .
20卷 第12期
所属人体系统:
其他
|
头颈部肿瘤
European Association of Neuro-Oncology
EUropean RAre CANcer
Medulloblastoma
Diagnosis
Treatment
Follow-up
Guideline
指南简介
原文链接
SIU-ICUD Recommendations on Bladder Cancer: Systemic Therapy for Metastatic Bladder Cancer
2019年 发布于
World J Urol
37卷 第1期
所属人体系统:
泌尿
|
膀胱肿瘤
Société Internationale D'UrologieInternational
Consultation on Urologic Diseases
Bladder Cancer
Checkpoint Inhibitors
Chemotherapy Immunotherapy
Urothelial Cancer
指南简介
原文链接
An International Collaborative Study from the EAU and ESMO to Develop Consensus Statements for Muscle Invasive Bladder Cancer
2019年 发布于
European Urology, Supplements
18卷 第1期
所属人体系统:
泌尿
|
膀胱肿瘤
European Association of Urology
European Society for Medical Oncology
Muscle Invasive Bladder Cancer
Consensus
指南简介
原文链接
SIU-ICUD Consultation on Bladder Cancer: Treatment of Muscle-invasive Bladder Cancer
2019年 发布于
World J Urol
37卷 第1期
所属人体系统:
泌尿
|
膀胱肿瘤
无
Adjuvant Chemotherapy
Bladder-sparing
Chemoradiation
Enhanced Recovery after Surgery
Muscle-invasive Bladder Cancer
Neoadjuvant Chemotherapy
Radical Cystectomy
Transurethral Resection of Bladder Tumor
Trimodal
Urothelial Carcinoma of Bladder
Variant Histology
指南简介
原文链接
Canadian Urological Association Guideline: Muscle-invasive Bladder Cancer
2019年 发布于
Canadian Urological Association Journal
13卷 第8期
所属人体系统:
泌尿
|
膀胱肿瘤
Canadian Urological Association
Muscle-invasive Bladder Cancer
Guideline
指南简介
原文链接
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-an International Collaborative Multi-stakeholder Effort: Under the Auspices of the EAU and ESMO Guidelines Committees
2019年 发布于
Ann Oncol
30卷 第11期
所属人体系统:
泌尿
|
膀胱肿瘤
European Association of Urology
European Society for Medical Oncology
Delphi
Bladder Cancer
Consensus
Diagnosis
Follow-up
Treatment
指南简介
原文链接
SEOM Clinical Guideline for Treatment of Muscle-invasive and Metastatic Urothelial Bladder Cancer (2018)
2019年 发布于
Clin Transl Oncol
21卷 第1期
所属人体系统:
泌尿
|
膀胱肿瘤
Spanish Society of Medical Oncology
Bladder Cancer
Chemotherapy
Cystectomy
Immune Checkpoint Inhibitors
指南简介
原文链接
ACR Appropriateness Criteria® Post-Treatment Surveillance of Bladder Cancer
2019年 发布于
J Am Coll Radiol
16卷 第11S期
所属人体系统:
泌尿
|
膀胱肿瘤
American College of Radiology Appropriateness Criteria
AUC
Appropriate Use Criteria
Appropriateness Criteria
Bladder Cancer
Muscle Invasive Bladder Cancer
Nonmuscle Invasive Bladder Cancer
Surveillance
指南简介
原文链接
JSH Practical Guidelines for Hematological Malignancies, 2018: II. Lymphoma-6. Burkitt Lymphoma (BL)
2019年 发布于
Int J Hematol
110卷 第3期
所属人体系统:
循环
|
淋巴瘤
Japanese Society of Hematology
Burkitt Lymphoma
BL
Hematological Malignancies
Guideline
指南简介
原文链接
European Association of Urology Guidelines on Renal Cell Carcinoma: the 2019 Update
2019年 发布于
Eur Urol
75卷 第5期
所属人体系统:
泌尿
|
肾癌
European Association of Urology
The European Association of Urology Renal Cell Carcinoma Guideline Panel Has Thoroughly Evaluated the Available Research Data on Kidney Cancer to Establish International Standards for the Care of Kidney Cancer Patients
指南简介
原文链接
Patients with Cardiac Implantable Electronic Devices Undergoing Radiotherapy in Poland. Expert Opinion of the Heart Rhythm Section of the Polish Cardiac Society and the Polish Society of Radiation Oncology
2019年 发布于
Kardiol Pol
77卷 第11期
所属人体系统:
其他
|
治疗方案
Heart Rhythm Section of the Polish Cardiac Society and the Polish Society of Radiation Oncology
Oncology
Radiotherapy
Cardiac Implantable Electronic Devices
Guideline
指南简介
原文链接
Minimally Invasive Surgery in Pediatric Oncology: Proposal of Guidelines
2019年 发布于
Anticancer Res
39卷 第11期
所属人体系统:
其他
|
治疗方案
无
Minimally Invasive Surgery
Wilms Tumor
Lung Metastases
Neuroblastoma
Ovarian Tumor
Pediatric Oncology
指南简介
原文链接
Palliativmedizin Für Patienten Mit Einer Nicht Heilbaren Krebserkrankung (Leitlinienprogramm Onkologie Von AWMF, DKG Und DKH)(English Title Translation: Palliative Care for Patients with Incurable Cancer)
2019年
所属人体系统:
其他
|
治疗方案
Arbeitsgemeinschaft Der Wissenschaftlichen Medizinischen Fachgesellschaften
Incurable Cancer
Palliative Care
counselling
Management
指南简介
原文链接
Diagnostic Value of Imaging (ultrasonography, Doppler, CT, MR, PET-CT) for the Diagnosis of a Suspicious Ovarian Mass and Staging of Ovarian, Tubal Or Primary Peritoneal Cancer: Article Drafted from the French Guidelines in Oncology Entitled `Initial Man
2019年 发布于
Gynecol Obstet Fertil Senol
47卷 第2期
所属人体系统:
其他
|
腹膜肿瘤
FRANCOGYN (Groupe Français De Recherche En Chirurgie Oncologique Et Gynécologique)
Au CNGOF (Collège National Des Gynécologues Obstétriciens Français)
À La SFOG (Société Française D’oncologie Gynécologique Et Au Groupe GINECO-ARCAGY (Groupe D’investigateurs Nationaux Pour L’étude Des Cancers Ovariens Et Du Sein – Association De Recherche Sur Les Cancers Dont Gynécologiques) Et Sont Labellisées Par L’INCa (Institut National Du Cancer).
Transvaginal Ultrasound Is the First-line Examination Allowing Characterizing 80 to 90% of Adnexal Masses (LP1). If Performed by an Expert
a Subjective Analysis Is Optimal. If Performed by a Non-expert
Combining the Use of Simple Rules with Subjective Analysis Can Achieve the Diagnostic Performance of an Expert (LP1). Whichever the Chosen Model (subjective Analysis by an Expert Or Combination of the Simple Rules with a Subjective Analysis by a Non-expert)
a Second-line Examination Will Have to Be Proposed in the Complex Or Indeterminate Cases (about 20% of the Masses) (grade A). the Best-performing Second-line Test for Characterization Is Pelvic MRI (LP1). If Read by an Expert
a Pathological Hypothesis Can Or Should Be Suggested (grade D). in Case of Non-expert Reading
the Use of the ADNEXMR Score Allows a Reliable Assessment of the Positive Predictive Value of Malignancy to Guide the Patient Towards the Best Management (gradeC). for Preoperative Assessment and Evaluation of Resectability of Ovarian
Fallopian Tube Or Primary Peritoneal Cancer
It Is Recommended to Perform a Chest Abdomen and Pelvis CT with Contrast Agent Injection (LP2
Grade B). in the Event of a Contraindication to the Injection of Iodinated Contrast Agent (severe Renal Insufficiency
GFR <30mL/min)
an Abdomen and Pelvis MRI Completed with a Non-injected Chest CT May Be Proposed (LP3
Grade C). by Analogy
the Same Examinations Are Recommended to Evaluate the Disease after Neo-adjuvant Chemotherapy (LP3
Recommendation Grade C). Further Studies Will Be Required to Determine Whether PET-CT Provides Better Lymph Node Assessment Before Retroperitoneal and Pelvic Lymphadenectomy. PET-CT May Be Used to Eliminate Lymph Node Involvement in the Absence of Suspicious Lymph Nodes on Morphological Examination (LP3
Grade C). the Report Should Specify the Localizations Leading to a Risk of Incomplete Cytoreductive Surgery and Lesions Outside the Field Explored During Surgery.
指南简介
原文链接
Management of Epithelial Cancer of the Ovary, Fallopian Tube, and Primary Peritoneum. Short Text of the French Clinical Practice Guidelines Issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and Endorsed by INCa
2019年 发布于
Eur J Obstet Gynecol Reprod Biol
236卷 第_期
所属人体系统:
其他
|
腹膜肿瘤
FRANçais De Recherche En Chirurgie Oncologique Et GYNécologique (FRANCOGYN)
Le Collège National Des Gynécologues Et Obstétriciens Français (CNGOF)
La Société Française D’oncologie Gynécologique (SFOG) Et Le Groupe D’investigateurs National Des Études Des Cancers Ovariens Et Du Sein (GINECO-ARCAGY) Et De L’institut National Du Cancer (INCa)
An MRI Is Recommended for an Ovarian Mass That Is Indeterminate on Ultrasound. the ROMA Score (combining CA125 and HE4) Can Also Be Calculated (Grade A). in Presumed Early-stage Ovarian Or Tubal Cancers
the Following Procedures Should Be Performed: an Omentectomy (at a Minimum
Infracolic)
an Appendectomy
Multiple Peritoneal Biopsies
Peritoneal Cytology (grade C)
and Pelvic and Para-aortic Lymphadenectomies (Grade B) for All Histologic Types
Except the Expansile Mucinous Subtypes
for Which Lymphadenectomies Can Be Omitted (grade C). Minimally Invasive Surgery Is Recommended for Early-stage Ovarian Cancer
When There Is No Risk of Tumor Rupture (grade B). Adjuvant Chemotherapy by Carboplatin and Paclitaxel Is Recommended for All High-grade Ovarian and Tubal Cancers (FIGO Stages I-IIA) (grade A). for FIGO Stage III Or IV Ovarian
Tubal
and Primary Peritoneal Cancers
a Contrast-enhanced Computed Tomography (CT) Scan of the Thorax/abdomen/pelvis Is Recommended (Grade B)
as Well as Laparoscopic Exploration to Take Multiple Biopsies (grade A) and a Carcinomatosis Score (Fagotti Score at a Minimum) (grade C) to Assess the Possibility of Complete Surgery (i.e.
Leaving No Macroscopic Tumor Residue). Complete Surgery by a Midline Laparotomy Is Recommended for Advanced Ovarian
Tubal
Or Primary Peritoneal Cancers (grade B). for Advanced Cancers
Para-aortic and Pelvic Lymphadenectomies Are Recommended When Metastatic Adenopathy Is Clinically Or Radiologically Suspected (grade B). When Adenopathy Is Not Suspected and When Complete Peritoneal Surgery Is Performed as the Initial Surgery for Advanced Cancer
the Lymphadenectomies Can Be Omitted Because They Do Not Modify Either the Medical Treatment Or Overall Survival (grade B). Primary Surgery (before Other Treatment) Is Recommended Whenever It Appears Possible to Leave No Tumor Residue (grade B). after Primary Surgery Is Complete
6 Cycles of Intravenous Chemotherapy (grade A) Are Recommended
Or a Discussion with the Patient About Intraperitoneal Chemotherapy
According to Her Risk-benefit Ratio. after Complete Interval Surgery for FIGO Stage III Disease
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Can Be Proposed
in Accordance with the Modalities of the OV-HIPEC Trial (grade B). in Cases of Postoperative Tumor Residue Or in FIGO Stage IV Tumors
Chemotherapy Associated with Bevacizumab Is Recommended (grade A).
指南简介
原文链接
Management of Epithelial Cancer of the Ovary, Fallopian Tube, and Primary Peritoneum. Long Text of the Joint French Clinical Practice Guidelines Issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and Endorsed by INCa. Part 1: Diagnostic Exploration and Staging, Surgery, Perioperative Care, and Pathology
2019年 发布于
Journal of Gynecology Obstetrics and Human Reproduction
48卷 第6期
所属人体系统:
其他
|
腹膜肿瘤
FRANçais De Recherche En Chirurgie Oncologique Et GYNécologique (FRANCOGYN)
Le Collège National Des Gynécologues Et Obstétriciens Français (CNGOF)
La Société Française D’oncologie Gynécologique (SFOG) Et Le Groupe D’investigateurs National Des Études Des Cancers Ovariens Et Du Sein (GINECO-ARCAGY) Et De L’institut National Du Cancer (INCa)
An MRI Is Recommended for an Ovarian Mass That Is Indeterminate on Ultrasound. the ROMA Score (combining CA125 and HE4) Can Also Be Calculated (grade A). in Presumed Early-stage Ovarian Or Tubal Cancers
the Following Procedures Should Be Performed: an Omentectomy (at a Minimum
Infracolic)
an Appendectomy
Multiple Peritoneal Biopsies
Peritoneal Cytology (grade C)
and Pelvic and Para-aortic Lymphadenectomies (grade B) for All Histologic Types
Except the Expansile Mucinous Subtypes
for Which Lymphadenectomies Can Be Omitted (grade C). Minimally Invasive Surgery Is Recommended for Early-stage Ovarian Cancer
When There Is No Risk of Tumor Rupture (grade B). for FIGO Stages III Or IV Ovarian
Tubal
and Primary Peritoneal Cancers
a Contrast-enhanced Computed Tomography (CT) Scan of the Thorax/abdomen/pelvis Is Recommended (grade B)
as Well as Laparoscopic Exploration to Take Multiple Biopsies (grade A) and a Carcinomatosis Score (Fagotti Score at a Minimum) (grade C) to Assess the Possibility of Complete Surgery (i.e.
Leaving No Macroscopic Tumor Residue). Complete Surgery by a Midline Laparotomy Is Recommended for Advanced Ovarian
Tubal
Or Primary Peritoneal Cancer (grade B). for Advanced Cancers
Para-aortic and Pelvic Lymphadenectomies Are Recommended When Metastatic Adenopathy Is Clinically Or Radiologically Suspected (grade B). When Adenopathy Is Not Suspected and When Complete Peritoneal Surgery Is Performed as the Initial Surgery for Advanced Cancer
the Lymphadenectomies Can Be Omitted Because They Do Not Modify Either the Medical Treatment Or Overall Survival (grade B). Primary Surgery (before Other Treatment) Is Recommended Whenever It Appears Possible to Leave No Tumor Residue (grade B).
指南简介
原文链接
Expert Consensus Workshop Report: Guidelines for Thermal Ablation of Primary and Metastatic Lung Tumors (2018 Edition)
2018年 发布于
J Cancer Res Ther
14卷 第4期
所属人体系统:
呼吸
|
肺癌
Minimally Invasive Treatment of Lung Cancer Branch
Professional Committee of Minimally Invasive Treatment of Cancer of the Chinese Anti-Cancer Association and Committee on Tumor Ablations
Chinese College of Interventionalists
Cryoablation
Guidelines
Lung Tumors
Thermal Ablation
Laser Ablation
Microwave Ablation
Radiofrequency Ablation
指南简介
原文链接
Minimal/measurable Residual Disease in AML: a Consensus Document from the European LeukemiaNet MRD Working Party
2018年 发布于
Blood
131卷 第12期
所属人体系统:
循环
|
白血病
European LeukemiaNet MRD Working Party
Measurable Residual Disease
acute Myeloid Leukemia
consensus
指南简介
原文链接
Dinutuximab Beta for Treating Neuroblastoma
2018年 发布于
National Institute for Health and Care Excellence
卷 第期
所属人体系统:
神经
|
神经细胞瘤
National Institute for Health and Care Excellence
Neuroblastoma
treatment
Dinutuximab
指南简介
原文链接
首页
上一页
1
2
3
4
5
6
7
8
下一页
尾页
共147条,每页显示
20条
50条
100条
跳转至第
页
确定